A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro
- 15 August 2008
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 119 (1-2) , 71-77
- https://doi.org/10.1016/j.imlet.2008.04.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Selection of SARS-Coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on miceVirology, 2007
- Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome CoronavirusMicrobiology and Molecular Biology Reviews, 2005
- Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with ReceptorScience, 2005
- SARS vaccine: progress and challenge.2005
- The Caveolin-1 Binding Domain of HIV-1 Glycoprotein gp41 Is an Efficient B Cell Epitope Vaccine Candidate against Virus InfectionImmunity, 2004
- Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing AntibodiesJournal of Virology, 2004
- S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected PatientsJournal of Virology, 2004
- Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organsProceedings of the National Academy of Sciences, 2000
- In vivorole of B lymphocytes in somatic transgene immunizationProceedings of the National Academy of Sciences, 1997
- Long-term persistence of plasmid DNA and foreign gone expression in mouse muscleHuman Molecular Genetics, 1992